Literature DB >> 17078460

A brief history of human constitutionology.

Kuang Diaoyuan1, Song Yongxia.   

Abstract

Human constitutionology studies human itself, which was proposed by Dr. Kuang. The study on human constitution in Chinese medicine has ever increased since the late 1970s. This review on the development of human constitutionology in Chinese Traditional Medicine (TCM) and western medicine is expected to give people with a different background to understand the establishment of this new subject, and its significance in promoting modernization of TCM and multi-disciplinary collaboration in human study and as an individualized model guiding the re-orientation of modern medicine.

Entities:  

Mesh:

Year:  2006        PMID: 17078460

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  4 in total

1.  Reduced MLH3 Expression in the Syndrome of Gan-Shen Yin Deficiency in Patients with Different Diseases.

Authors:  Juan Du; Maofeng Zhong; Dong Liu; Shufang Liang; Xiaolin Liu; Binbin Cheng; Yani Zhang; Zifei Yin; Yuan Wang; Changquan Ling
Journal:  Evid Based Complement Alternat Med       Date:  2017-09-26       Impact factor: 2.629

2.  The Relationships between Leptin, Genotype, and Chinese Medicine Body Constitution for Obesity.

Authors:  Hsiang-I Hou; Hsing-Yu Chen; Jang-Jih Lu; Shih-Cheng Chang; Hsueh-Yu Li; Kun-Hao Jiang; Jiun-Liang Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-07       Impact factor: 2.629

3.  Reduced health-related quality of life in body constitutions of yin-xu, and yang-xu, stasis in patients with type 2 diabetes: taichung diabetic body constitution study.

Authors:  Chia-I Tsai; Yi-Chang Su; Shih-Yi Lin; I-Te Lee; Cheng-Hung Lee; Tsai-Chung Li
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-29       Impact factor: 2.629

4.  Study on Yang-Xu Using Body Constitution Questionnaire and Blood Variables in Healthy Volunteers.

Authors:  Hong-Jhang Chen; Yii-Jeng Lin; Pei-Chen Wu; Wei-Hsiang Hsu; Wan-Chung Hu; Trong-Neng Wu; Fang-Pey Chen; Yun-Lian Lin
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-31       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.